Valerie Hurdle1, Jean-Francois Ouellet2, Elijah Dixon1, Thomas J Howard3, Keith D Lillemoe4, Charles M Vollmer5, Francis R Sutherland1, Chad G Ball1. 1. The Department of Surgery, University of Calgary, Calgary, Alta. 2. The Department of Surgery, Laval University, Quebec City, Que. 3. The Department of Surgery, Community Health Network, Indianapolis, Ind.. 4. The Department of Surgery, Harvard University, Massachusetts General Hospital, Boston, Mass. 5. The Department of Surgery, University of Pennsylvania, Philadelphia, PA.
Abstract
BACKGROUND: Management and palliation of pancreatic head adenocarcinoma is challenging. End-of-life decision-making is a variable process involving multiple factors. METHODS: We conducted a qualitative, physician-based, 40-question international survey characterizing the impact of medical, religious, social, training and system factors on care. RESULTS: A total of 258 international clinicians completed the survey. Respondents were typically fellowship-trained (78%), with a mean of 16 years' experience in a university-affiliated (93%) hepato-pancreato-biliary group (96%) practice. Most (91%) believed resection is potentially curative. Most patients were discussed preoperatively by multidisciplinary teams (94%) and medical assessment clinics (68%), but rarely critical care (21%). Intraoperative surgical palliation included double bypass or no intervention for locally advanced nonresectable tumours (41% and 49% v. 14% and 85%, respectively, for patients with hepatic metastases). Postoperative admission to the intensive care unit was frequent (58%). Severe postoperative complications were often treated with aggressive cardiopulmonary resuscitation, intubation and critical care (96%), with no defined time points for futility (74%). Admitting surgeons guided most end-of-life decisions (97%). Formal medical futility laws were rarely available (26%). Insurance status did not alter treatment (97%) or palliation (95%) in non-universal care regions. Clinician experience, regional culture and training background impacted treatment (all p < 0.05). CONCLUSION: Despite remarkable overall agreement, geographic and training differences are evident in the treatment and palliation of pancreatic head adenocarcinoma.
BACKGROUND: Management and palliation of pancreatic head adenocarcinoma is challenging. End-of-life decision-making is a variable process involving multiple factors. METHODS: We conducted a qualitative, physician-based, 40-question international survey characterizing the impact of medical, religious, social, training and system factors on care. RESULTS: A total of 258 international clinicians completed the survey. Respondents were typically fellowship-trained (78%), with a mean of 16 years' experience in a university-affiliated (93%) hepato-pancreato-biliary group (96%) practice. Most (91%) believed resection is potentially curative. Most patients were discussed preoperatively by multidisciplinary teams (94%) and medical assessment clinics (68%), but rarely critical care (21%). Intraoperative surgical palliation included double bypass or no intervention for locally advanced nonresectable tumours (41% and 49% v. 14% and 85%, respectively, for patients with hepatic metastases). Postoperative admission to the intensive care unit was frequent (58%). Severe postoperative complications were often treated with aggressive cardiopulmonary resuscitation, intubation and critical care (96%), with no defined time points for futility (74%). Admitting surgeons guided most end-of-life decisions (97%). Formal medical futility laws were rarely available (26%). Insurance status did not alter treatment (97%) or palliation (95%) in non-universal care regions. Clinician experience, regional culture and training background impacted treatment (all p < 0.05). CONCLUSION: Despite remarkable overall agreement, geographic and training differences are evident in the treatment and palliation of pancreatic head adenocarcinoma.
Authors: N G Smedira; B H Evans; L S Grais; N H Cohen; B Lo; M Cooke; W P Schecter; C Fink; E Epstein-Jaffe; C May Journal: N Engl J Med Date: 1990-02-01 Impact factor: 91.245
Authors: E Alemayehu; D W Molloy; G H Guyatt; J Singer; G Penington; J Basile; M Eisemann; P Finucane; M E McMurdo; C Powell Journal: CMAJ Date: 1991-05-01 Impact factor: 8.262
Authors: Derek C Angus; Amber E Barnato; Walter T Linde-Zwirble; Lisa A Weissfeld; R Scott Watson; Tim Rickert; Gordon D Rubenfeld Journal: Crit Care Med Date: 2004-03 Impact factor: 7.598
Authors: Anthony Yang; Haley M Zylberberg; Sheila D Rustgi; Sunil P Amin; Ariel Bar-Mashiah; Paolo Boffetta; Aimee L Lucas Journal: Sci Rep Date: 2021-01-13 Impact factor: 4.379
Authors: Blanche Blumenthal; Christina W Lee; C Ann Vitous; Alexandria J Robbins; Ana C De Roo; Mary Byrnes; Pasithorn A Suwanabol Journal: Ann Palliat Med Date: 2020-09-10